MedTrace Logo

Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America

NCT04089488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2023-09-01

Study results available
· View outcomes & findings →

Summary

This trial studies the frequency of incident and prevalent of cancer in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) at cancer centers in Latin America. By counting how many people living with HIV/AIDS have cancer at these specific centers, researchers may better understand how they are being treated and cared for. This may help researchers to understand what new studies may be helpful for those areas in the future.

Conditions

  • HIV Infection
  • Human Immunodeficiency Virus 1 Positive
  • Malignant Neoplasm
  • Recurrent Malignant Neoplasm

Interventions

OTHER

Medical Chart Review

Correlative studies

OTHER

Survey Administration

Respond to surveys

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • University of Arkansas

    collaborator OTHER

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Robert M Strother · AIDS Malignancy Consortium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2021-10-18
Completion
2021-10-18

Countries

  • Argentina
  • Brazil
  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04089488 on ClinicalTrials.gov